Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Heart and Stroke Foundation of Ontario Sunnybrook Health Sciences Centre |
---|---|
Information provided by: | Heart and Stroke Foundation of Ontario |
ClinicalTrials.gov Identifier: | NCT00446914 |
This program developed by the HSFO aims at helping people of Ontario and their primary healthcare providers better diagnose, manage and control high blood pressure. The High Blood Pressure Strategy brings together healthcare providers and patients to improve the way in which family doctors, nurse practitioners and pharmacists work together and with patients towards improved control of high blood pressure through the use of evidence-informed tools combined with local systems change.
Condition | Intervention |
---|---|
Hypertension |
Behavioral: Systems Change (High Blood Pressure Strategy) |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | High Blood Pressure Strategy: Hypertension Management Initiative Study |
Estimated Enrollment: | 5000 |
Study Start Date: | January 2007 |
Estimated Study Completion Date: | January 2010 |
Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
Approximately 5,000 patients will participate in the study at 11 family practice sites throughout Ontario. Each of the 11 clinic sites will be randomised to either intervention or delayed intervention 9 months later. The intervention is a systems change involving interprofessional education and management tools to bring together physicians, nurses and pharmacists with the patient. Patients will be monitored by their family doctor or nurse practitioner at scheduled follow-up visits during a period of 36 months for an effect of the intervention over time on the patient's blood pressure.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Sheldon W Tobe, MD, FRCP(C) | 416-480-6901 | sheldon.tobe@sunnybrook.ca |
Canada, Ontario | |
Heart and Stroke Foundation of Ontario | Recruiting |
Toronto, Ontario, Canada, M4P1E4 | |
Contact: Margaret Moy Lum-Kwong, BSc.N, MBA, CHE 416-489-7111 ext 445 moylumkwong@hsf.on.ca | |
Contact: Shirley Von Sychowski, BA, MA 416-489-7111 ext 339 svsychowski@hsf.on.ca |
Principal Investigator: | Sheldon W Tobe, MD, FRCP(C) | Sunnybrook Health Sciences Centre |
Principal Investigator: | Margaret Moy Lum-Kwong, BSc.N., MBA, CHE | Heart and Stroke Foundation of Ontario |
Principal Investigator: | Shirley Von Sychowski, BA, MA | Heart and Stroke Foundation of Ontario |
Responsible Party: | Sunnybrook Health Sciences Centre ( Sheldon Tobe ) |
Study ID Numbers: | 474-2006 |
Study First Received: | March 12, 2007 |
Last Updated: | August 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00446914 |
Health Authority: | Canada: Ethics Review Committee |
Hypertension Blood Pressure |
Vascular Diseases Hypertension |
Cardiovascular Diseases |